UTHR ▼ -0.1% - United Therapeutics Corporation $UTHR United Therapeutics Corporation Announces First Transplant in EXTEND Clinical Trial of UThymoKidney™ in Patients with End-Stage Renal Disease 20-NOV-2026 07:00 AM ET